Post-operative nausea and vomiting (PONV) market to rise from $2.11B in 2024 to $2.97B in 2029, driven by innovations in ...

Pakistan’s pharmaceutical sector stands as one of the steadily growing industries within the country’s economy.

The inhaler, with an older propellant, is already approved in Europe for the treatment of adults with chronic obstructive ...

Three new appointments and two reappointments made A series of appointments and reappointments have been made to the Board of Royal Botanic Gardens ...

The domestic equity market could experience heightened volatility in the coming week, driven by a mix of global signals and ...

The combinations are also approved for relapsed or refractory multiple myeloma in Japan, the UK and other markets including ...

CEO Emma Walmsley’s 40-bln-pound 2031 sales target looks fanciful after another disappointing drug trial. A healthy balance ...

The European Union has approved GSK's drug Blenrep to treat relapsed or treatment-resistant forms of a cancer affecting blood ...

In an import contrast to events in the USA, UK pharma major GSK late Thursday announced the approval of Blenrep (belantamab ...

GSK is taking to the airwaves to get the message out about respiratory syncytial virus (RSV), presenting a TV special about ...

The European Union has given regulatory approval to GSK's drug, Blenrep, for treating relapsed or treatment-resistant forms of blood plasma cell cancer.